2015 Digital Health Drug Development 
Digital Health Today
FEBRUARY 24, 2020
It passed the House in July of 2015, but was not signed into law – largely because of the political stigma associated with anything that could be perceived as benefiting big pharma – when in reality this is needed to help thousands of people. Digital Health Today would not be possible without our valuable partners.
Digital Health Global
JUNE 2, 2024
About Massive Bio: Massive Bio’s vision is to cover entire Pharma value chain with disruptive solutions to improve entire ecosystem from drug development to commercialization. Founded in 2015 by a team of clinical, technology, and M&A executives, Massive Bio boasts a global presence with nearly 100 people across 12 countries.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
JUNE 17, 2023
The market for digital health is maturing. When the Teladoc Livongo merger was announced in 2020, the market for digital health was still in its early stages. However, the market has matured since then, and there are now a number of other digital health companies competing with Teladoc.
Digital Health Global
JUNE 20, 2023
These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Daniel Veres, M.D.,
Digital Health Global
OCTOBER 3, 2023
a trailblazing entity in the realm of digital health technology, proudly announces a pivotal advancement in clinical trial recruitment, fortified by a strategic relationship with Evernorth Health, Inc (ENI). Contacts Media Contact: Massive Bio Erkan Terzi Chief Marketing Officer +1 844 627 7246 pr@massivebio.com
Expert insights. Personalized for you.
104 
Let's personalize your content